Hydroxychloroquine Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Research Scope & Content Outline

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Research Methodology
                    1.3. Research Scope & Assumption
                    1.4. Information Procurement
                         1.4.1. Purchased Database
                         1.4.2. GVR’s Internal Database
                         1.4.3. Secondary Sources & Third-Party Perspectives
                         1.4.4. Primary Research
                    1.5. Information Analysis
                         1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Data Validation & Publishing
Chapter 2. Hydroxychloroquine Market Intelligence
                    2.1. Category Definition
                    2.2. Category Intelligence
                         2.2.1. Market Size
                         2.2.2. Trends
                         2.2.3. Drivers
                         2.2.4. Challenges
                         2.2.5. Regional/ End-use Application Insights
                    2.3. Technology
                         2.3.1. Emerging Technology
                         2.3.2. Best Practices in the Industry
                    2.4. Regulatory Landscape
                    2.5. Porter’s Five Forces Analysis
                         2.5.1. Bargaining power of suppliers
                         2.5.2. Bargaining power of buyers
                         2.5.3. Threat of substitutes
                         2.5.4. Threat of new entrants
                         2.5.5. Competitive rivalry
Chapter 3. Hydroxychloroquine - Supplier Intelligence
                    3.1. Identification of top 12 suppliers
                         3.1.1. Actiza Pharmaceutical Private Limited
                         3.1.2. Bayer AG
                         3.1.3. Bliss GVS Pharma Limited
                         3.1.4. Cipla Inc.
                         3.1.5. GeoVax, Inc.
                         3.1.6. Ipca Laboratories Ltd.
                         3.1.7. Lupin Limited
                         3.1.8. Pfizer Inc.
                         3.1.9. Sanofi SA
                         3.1.10. Sun Pharmaceutical Industries Ltd.
                         3.1.11. Teva Pharmaceutical Industries Ltd.
                         3.1.12. Zydus Lifesciences Limited
                    3.2. Hydroxychloroquine Supplier Landscape
                    3.3. Hydroxychloroquine Supplier Ranking Methodology
                         3.3.1. Supplier Operational Capabilities
                              3.3.1.1. Years in Service
                              3.3.1.2. Geographic Service Provision
                              3.3.1.3. Employee Strength
                              3.3.1.4. Revenue Generated
                              3.3.1.5. Certifications
                              3.3.1.6. Regulatory Compliance
                         3.3.2. Supplier Functional Capabilities
                              3.3.2.1. Product Specification & Quality
                              3.3.2.2. Product Safety
                              3.3.2.3. Pharmaceutical Form (Tablet/Capsule)
                              3.3.2.4. Lead Time
                              3.3.2.5. Production Capacity
                              3.3.2.6. Others
                    3.4. Hydroxychloroquine - Supplier Scoring Criteria
                    3.5. Hydroxychloroquine - Supplier Positional Matrix (SPM)
                         3.5.1. Rulers
                         3.5.2. Challengers
                         3.5.3. Loungers
                         3.5.4. Niches
                    3.6. Hydroxychloroquine - Supplier Market Concentration
                         3.6.1. Industry structure
                    3.7. Recommended Suppliers
                         3.7.1. Supplier 1 with detailed profile
                         3.7.2. Supplier 2 with detailed profile
                         3.7.3. Supplier 3 with detailed profile
Chapter 4. Competitive Landscape
                    4.1. Recent Supplier Developments with Measured Impact
                         4.1.1. Joint Ventures
                         4.1.2. Mergers & Acquisitions
                         4.1.3. Collaborations or Partnerships
                         4.1.4. Other major developments
                    4.2. Supply - Demand Analysis
                         4.2.1. Supply Analysis
                         4.2.2. Demand Analysis
Chapter 5. Hydroxychloroquine - Pricing and Cost Intelligence
                    5.1. Cost Structure Overview
                         5.1.1. Raw materials (active pharmaceutical ingredients)
                         5.1.2. Labor
                         5.1.3. Machinery and production process
                         5.1.4. Facilities
                         5.1.5. Storage and Transportation
                         5.1.6. Others
                    5.2. Factors influencing the prices of Hydroxychloroquine
                         5.2.1. Strength Prescribed
                         5.2.2. Market Competition
                         5.2.3. Effectiveness of drug
                         5.2.4. Others
                    5.3. Hydroxychloroquine - Pricing Model Analysis
                         5.3.1. Cost plus pricing or,
                         5.3.2. Volume-based pricing or,
                         5.3.3. Others
                    5.4. Hydroxychloroquine Prices - Suppliers Quotation (Few Examples)
Chapter 6. Sourcing Intelligence
                    6.1. Engagement Model
                         6.1.1. Fully Outsourcing Model or,
                         6.1.2. Partial/Hybrid Outsourcing Model or,
                         6.1.3. In-house Product Development Model or,
                         6.1.4. Shared Service Model
                    6.2. Operating Model
                         6.2.1. Basic Provider or,
                         6.2.2. Approved Provider or,
                         6.2.3. Others
                    6.3. KPI/SLA Elements
                    6.4. Negotiation Strategies
                    6.5. LCC/BCC Sourcing Analysis
                         6.5.1. India
                         6.5.2. China
                         6.5.3. U.S.
                         6.5.4. Insights on Top 2 LCC/BCC Countries